TechValidate Research on QIAGEN Digital Insights

These pages present data that TechValidate has sourced via direct research with verified customers and users of QIAGEN Digital Insights. TechValidate stands behind the authenticity of all published data. Learn more »



6,220 Customers Surveyed

42,241 Data Points Collected

352 Published TechFacts

38 Published Charts

23 Published Case Studies



Featured Research Collections for QIAGEN Digital Insights

Curated collections and slideshows of TechValidate research data on QIAGEN Digital Insights.



Selected Research Highlights


Top Reasons for Deploying IPA for RNA-Seq

What types of challenges did deploying IPA for RNA sequencing analysis solve for your laboratory?

Understanding the structure of different isoforms
13%
More precise measurement of transcripts
34%
Ability to distinguish different isoforms
26%
Identifying biologically relevant isoforms
40%
Other
28%

Simplify search for deleterious variants with Ingenuity Variant Analysis for Ion Reporter

It does simplify our work, and it’s essential to identify deleterious variants. Thanks to Ingenuity.

Juan Martin Marques, Lab Director, GeniaGeo

QIAGEN Bioinformatics Customer Satisfaction Rating

Esmaeil Ebrahime, an Associate Professor at University of Adelaide, would be very likely to recommend QIAGEN Bioinformatics for this reason:

Great support and the CLC Genomics support team is vey knowledgeable.

QIAGEN Digital Insights Customer Research

When you have identified a pathway from a metagenomic functional profiling analysis, which steps do you typically perform subsequently?

Identification of central nodes/enzymes as drug targets
25%
Identification of the phenotypic consequences of differential abundance/expression
69%
Identification of harmful/beneficial metabolites
35%
Other
8%

Case Study: Cornell University and Ingenuity Variant Analysis

Introduction

This case study of Cornell University is based on a March 2013 survey of Ingenuity Systems customers by TechValidate, a 3rd-party research service.

“Identifying the causal variants supported by high confidence literature is the key thing in which our institute is interested. Ingenuity makes it so simple and easy. [Our] thanks to Ingenuity.”

Challenges

  • Solved the following challenges by deploying Ingenuity Variant Analysis:
    • Realized faster and easier identification of causal variants
    • Improved access to biological content including primary sources
    • Improved sharing and collaboration capabilities
    • Eliminated the need for creating and maintaining own up-to-date database of biomedical literature
    • Enabled support for more studies by providing a self-service tool for colleagues and collaborators
  • Purchased Ingenuity Variant Analysis for the following reasons:
    • Access rich biological content in Ingenuity Knowledge Base plus additional sources of variant level content
    • Reduce time to identify variants worth following up on
    • Identify high impact, most compelling variants to follow up on
    • Collaborate and share easily with colleagues and peers

Use Case

  • Uses the following applications with Ingenuity Variant Analysis:
    • DNA sequencing – Whole Genome
  • Sequencing data is from the following platforms:
    • Illumina Genome Analyzer (GA) / HiSeq

Results

  • Chose Ingenuity Systems over the following solutions:
    • ANNOVAR
    • VAAST / Omicia
  • Saves > 3 days per sample using Ingenuity Variant Analysis for DNA variant annotation and analysis.
  • Reduced time to results by > 75% by using Ingenuity Variant Analysis for DNA variant annotation and analysis.
  • Rated the following Ingenuity Variant Analysis capabilities in terms of how differentiated they are compared to other data analysis solutions:
    • Speed: 5 (strongly differentiated)
    • Accurate evidence: 5 (strongly differentiated)
    • Accessibility/ ease of use: 5 (strongly differentiated)
    • Sharing with colleagues/peers: 5 (strongly differentiated)
    • Security: 5 (strongly differentiated)
  • Is extremely satisfied with the ease of use of Ingenuity Variant Analysis.

Case Study: QIMR and Ingenuity Variant Analysis

Introduction

This case study of QIMR is based on a March 2013 survey of Ingenuity Systems customers by TechValidate, a 3rd-party research service.

“[The] reduced reliance on our bioinformatics team allows for faster turn around for us, and thus greater availability of that team for other projects. The findings link to the supporting literature, which assists in identifying all the evidence that may otherwise have been missed.”

Challenges

  • Solved the following challenges by deploying Ingenuity Variant Analysis:
    • Realized faster and easier identification of causal variants
    • Improved access to biological content including primary sources
  • Purchased Ingenuity Variant Analysis for the following reasons:
    • Access rich biological content in Ingenuity Knowledge Base plus additional sources of variant level content
    • Reduce time to identify variants worth following up on

Use Case

  • Uses the following applications with Ingenuity Variant Analysis:
    • DNA sequencing – Whole Exome
    • DNA sequencing – Targeted / Gene Panel
  • Sequencing data is from the following platforms:
    • Illumina Genome Analyzer (GA) / HiSeq
    • Ion Torrent PGM
    • Complete Genomics

Results

  • Chose Ingenuity Systems over the following solutions:
    • In-house developed software
  • Saves 4 to 8 hours per sample using Ingenuity Variant Analysis for DNA variant annotation and analysis.
  • Reduced time to results by 50 to 74% by using Ingenuity Variant Analysis for DNA variant annotation and analysis.
  • Rated the following Ingenuity Variant Analysis capabilities in terms of how differentiated they are compared to other data analysis solutions:
    • Accurate evidence: 4 (very differentiated)
    • Accessibility/ ease of use: 5 (strongly differentiated)
    • Sharing with colleagues/peers: 3 (differentiated)
  • Is extremely satisfied with the ease of use of Ingenuity Variant Analysis.


More to Explore



About QIAGEN Digital Insights

QIAGEN offers industry-leading applications for the analysis, interpretation, and reporting of biological data. Understanding raw data is one of the most significant challenges in modern molecular methods. Data must be examined within the context of complex biological processes, and rapidly increasing throughput makes analyses time and labor intensive. QIAGEN’s portfolio of powerful tools addresses this bottleneck with innovative applications based on cutting-edge bioinformatics.

QIAGEN Digital Insights Website   QIAGEN Website